About Us
About Maysing Medtech
Singapore Maysing Medtech is a Singapore-headquartered company with footprints across S.E.A., Israel, and China. Our mission is to improve quality of life through early and personalized diagnoses across point-of-care and consumers’ homes, by working with world-class scientists and research teams to create innovative diagnostics solutions. We aim to deliver cutting-edge diagnostics solutions at an affordable price to the local and global markets, starting in Singapore, S.E.A., and China.
Our key product under development includes AIDS-related immune system assessment for immune damage and recovery after antiretroviral treatment (through in vitro diagnostic), which is backed by our patented technologies. Other products in the pipeline include tuberculosis drug resistance screening solution, early screening for bladder cancer, liquid biopsy, protein test & diagnoses through the tear, and the world's first breath gas detection product through Raman technology for the detection of Covid-19, diabetes, new drugs, cancer, and other diseases.
Singapore Maysing Medtech is teaming up with global innovation, investment, clinical, and healthcare service partners to leverage their proprietary expertise and distribution networks in specific countries and regions, and is being aspired to unlock the full potential of early and personalized diagnoses across the care continuum.
Team Up to Excel
Dr. Shang Hong
Fellow of The Chinese Academy of Engineering;
Vice president of the China Medical University. Over 30 years of research and development experience in the fields of AIDS, small molecule drugs, bacterial resistance, and novel detection reagents. Received the Second Prize for National Science and Technology Progress.
Prof Freddy Boey
President of the City University of Hong Kong. Former Deputy President (Innovation & Enterprise) of the National University of Singapore. Filed 118 patents and established several spin-offs. Research results were published in 361 top journals with 18,000 citations. Received Singapore's highest scientific award, the President's Award for Science and Technology in 2013. received the Singapore Public Administration Medal (Gold) in 2016.
Dr. Steve Fan Shiliang
B.S. from Peking University; M.S. joint degree from the National University of Singapore and MIT; Ph.D. from University of Montpellier, France. Executive director of Nanjing Tembusu Advanced Materials Research Institute; Received the "Thousand Experts" title in Jiangsu Province, and recognized as the "Foreign Expert" in Nanjing, Filed more than 30 patents.